Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Lucero Bautista"'
Publikováno v:
Current Enzyme Inhibition. 17:16-25
Introduction: 5α-reductase inhibitors have been proven useful for the treatment of prostate diseases, which can be due to the unregulated activity of 5α-reductase enzyme. This study was focused on determining the activity of four different derivati
Publikováno v:
Current Enzyme Inhibition. 15:179-189
Background:Benign prostatic hyperplasia and prostate cancer are androgen-dependent diseases, and dihydrotestosterone (DHT), a 5α-reduced metabolite of testosterone (T), has been implicated as a causative factor in the progression of these diseases.
Publikováno v:
Current Drug Targets. 19:1855-1865
Considerable progress has been made in learning about the physiology and biochemistry of the sebaceous glands and several of the diseases that affect this component of the skin. Of these diseases, acne has particular importance. It is associated with
Autor:
Marisol Bravo, Eugene Bratoeff, Isabel Moreno, Teresa Ramírez-Apan, Yvonne Heuze, Lucero Bautista, Aylin Viviana Silva-Ortiz, Juan Soriano, Marisa Cabeza
Publikováno v:
Bioorganic & Medicinal Chemistry. 25:1600-1607
The aim of this study was to synthesize several 16-dehydropregnenolone derivatives containing an imidazole ring at C-21 and a different ester moiety at C-3 as inhibitors of 5α-reductase 1 and 2 isoenzymes. Their binding capacity to the androgen rece
Publikováno v:
Journal of the Endocrine Society
Abstract: Metastatic prostate tumor cells mainly express type 1 5α-reductase and have been linked to antiandrogenic resistant prostate cancers. However, the isozyme of type 2 5α-reductase is mostly expressed in normal prostate epithelial cells and